Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Quarter

Conference/Earnings Calls Alerts

Glenmark Pharmaceuticals Ltd.

21 Aug 2023

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcript of the Earnings Call held on Monday, August 14, 2023 for the first quarter ended June 30, 2023 has been uploaded on the Company''s website.

pdf

Glenmark Pharmaceuticals Ltd.

14 Aug 2023

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q1 FY 2023-24 Earnings Call held on 14th August, 2023 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

14 Aug 2023

2116.30

3.14%

Glenmark Pharmaceuticals Results Earnings Call for Q1FY24

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Glenmark Pharmaceuticals Ltd.

25 May 2023

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call

pdf

Glenmark Pharmaceuticals Ltd.

22 May 2023

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q4 of FY 2022-23 Earnings Call held on 22nd May, 2023 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

22 May 2023

2116.30

3.14%

Glenmark Pharmaceuticals Ltd. Results Earnings Call for Q4FY23

Conference Call with Glenmark Pharmaceuticals Ltd. Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Glenmark Pharmaceuticals Ltd.

15 Feb 2023

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Earnings Call

pdf

Glenmark Pharmaceuticals Ltd.

13 Feb 2023

2116.30

3.14%

Glenmark Pharmaceuticals Results Earnings Call for Q3FY23

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.

audio

Glenmark Pharmaceuticals Ltd.

13 Feb 2023

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q3 of FY 2022-23 Earnings Call held on 13th February, 2023 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

18 Nov 2022

2116.30

3.14%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our letter dated 03rd November, 2022 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings call held on Monday, November 14, 2022 for the quarter and half year ended September 30, 2022 has been uploaded on the Company's website

pdf

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

Earnings Calls Podcast on